NexImmune (NEXI) News Today $1.34 -0.04 (-2.90%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 12, 2024 | investorplace.comNEXI Stock Alert: NexImmune Delists From NasdaqJuly 11, 2024 | investorplace.comWhat Is Going on With NexImmune (NEXI) Stock Today?May 26, 2024 | nasdaq.comNexImmune, Inc. Common Stock (NEXI) After-HoursMay 20, 2024 | msn.comNEXI Stock Earnings: NexImmune Reported Results for Q1 2024April 17, 2024 | investorplace.comNEXI Stock Earnings: NexImmune Reported Results for Q4 2023April 16, 2024 | theglobeandmail.comAcute Myeloid Leukemia Market Size is Expected to Grow by 2032 | DelveInsightApril 15, 2024 | msn.comPortage mulls company closure, pauses enrolment for lead clinical programmeApril 2, 2024 | msn.comXilio fires 21% of its workforce and reprioritises pipelineFebruary 7, 2024 | msn.comNexImmune Announces New Offerings in Recent Press ReleaseFebruary 6, 2024 | markets.businessinsider.comNexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesFebruary 6, 2024 | msn.comNexImmune Secures Funding Through Equity and Warrant SalesFebruary 3, 2024 | msn.comNexImmune Ends Stock Sale Agreement, Raises $5.1 MillionFebruary 2, 2024 | msn.comNexImmune slips after securities offeringFebruary 2, 2024 | finance.yahoo.comNexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesFebruary 2, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. January 31, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause." Trading set to resume at 10:01 AM. January 31, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 30, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 02:01 PM with a stated reason of "LULD pause."January 30, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 11:01 AM with a stated reason of "LULD pause." Trading set to resume at 11:01 AM. January 30, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 10:01 AM with a stated reason of "LULD pause."January 30, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 29, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 12:01 PM with a stated reason of "LULD pause." Trading set to resume at 12:01 PM. January 13, 2024 | nasdaq.comNexImmune, Inc. Common Stock (NEXI)January 10, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 9, 2024 | investorplace.comNexImmune (NEXI) Stock Rockets 80% Ahead of Potential LiquidationJanuary 9, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 10:01 AM with a stated reason of "LULD pause."January 9, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 9, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."January 5, 2024 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:01 AM with a stated reason of "LULD pause."December 26, 2023 | bizjournals.comNexImmune's future in limbo as Gaithersburg biotech extends liquidation voteDecember 10, 2023 | ca.finance.yahoo.comNexImmune, Inc. (NEXI) Stock Price, News, Quote & History - Yahoo FinanceDecember 4, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:12 AM with a stated reason of "LULD pause."December 1, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 02:12 PM with a stated reason of "LULD pause."December 1, 2023 | investorplace.comNEXI Stock Halted: What’s Going on With NexImmune Shares Today?December 1, 2023 | investorplace.comWhy Is NexImmune (NEXI) Stock Up 353% Today?December 1, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 08:12 AM with a stated reason of "News pending."November 23, 2023 | morningstar.comNexImmune Inc Ordinary Shares NEXINovember 8, 2023 | bizjournals.comGaithersburg’s NexImmune prepares to shut down, lay off ‘substantially all’ employeesNovember 6, 2023 | msn.comWhat's Going On With Neximmune (NEXI) Stock Monday?November 3, 2023 | msn.comWhy Neximmune (NEXI) Stock Is Getting HammeredNovember 3, 2023 | marketwatch.comNexImmune Shares Slide Premarket as Biotech Says It Will LiquidateNovember 3, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 10:11 AM with a stated reason of "LULD pause."November 3, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:11 AM with a stated reason of "LULD pause."November 3, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:11 AM with a stated reason of "LULD pause."November 3, 2023 | marketbeat.comTrading was temporarily halted for "NEXI" at 09:11 AM with a stated reason of "LULD pause."October 24, 2023 | finance.yahoo.comNexImmune, Yale, and JDRF Extend Research Partnership for Type 1 DiabetesOctober 19, 2023 | finance.yahoo.comNexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual MeetingOctober 18, 2023 | finanznachrichten.deNexImmune, Inc.: NexImmune Announces 1-for-25 Reverse Stock SplitOctober 18, 2023 | finance.yahoo.comNexImmune Announces 1-for-25 Reverse Stock SplitOctober 4, 2023 | msn.comEY report finds cracks in pharma supply chain operations Get NexImmune News Delivered to You Automatically Sign up to receive the latest news and ratings for NEXI and its competitors with MarketBeat's FREE daily newsletter. Email Address Get out of cash before the Fed's next meeting (Ad)"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains." Click here now to watch this exclusive interview NEXI Media Mentions By Week NEXI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEXI News Sentiment▼0.000.61▲Average Medical News Sentiment NEXI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEXI Articles This Week▼01▲NEXI Articles Average Week Get NexImmune News Delivered to You Automatically Sign up to receive the latest news and ratings for NEXI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Atreca News Today Kaleido Biosciences News Today Cadrenal Therapeutics News Today Sunshine Biopharma News Today Shuttle Pharmaceuticals News Today Sonoma Pharmaceuticals News Today Tenax Therapeutics News Today Xenetic Biosciences News Today Kazia Therapeutics News Today Galera Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEXI) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexImmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexImmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.